Prostate cancer drug that can halve death risk to be offered to thousands in England
At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects Thousands of men with advanced prostate cancer in England are to be offered a drug that can halve the risk of death. In guidance published on Friday, the National (…)
Site référencé:
The Guardian (South&CentralAsia)
3333.jpg?width=140&quality=85&auto=format&fit=max&s=4ef98f38f4c778416f19eff8a360aecc, 3333.jpg?width=460&quality=85&auto=format&fit=max&s=1150db78d91fedf560db661d7de6d353, 3333.jpg?width=700&quality=85&auto=format&fit=max&s=b88b50e1202d2797417341d7e43a97ab
The Guardian (South&CentralAsia)
Oscar Piastri admits Max Verstappen’s re-emergence in F1 title race is ‘bit of a surprise’
23/10/2025
The Ridge review – this hugely layered thriller is just masterly
23/10/2025
Go Ahead Eagles hold on to stun Aston Villa after Buendía’s spot-kick miss
23/10/2025
The Wanderers review – faith and infidelity in Brooklyn
23/10/2025
Soldier F case should serve as a caution for future Troubles prosecutions
23/10/2025
Reeves considers breaking manifesto pledge with income tax rise to fill £30bn gap
23/10/2025